Skip to content
Search

Latest Stories

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

She will rejoin the organisation after six years to head one of the country's largest NHS Trusts.

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard, who is set to step down as NHS England chief in April, has been appointed as the next chief executive of Guy’s and St Thomas’ NHS Foundation Trust.

Pritchard previously led the Trust from October 2015 to August 2019 before moving to NHS England, where she later became its first female chief executive in August 2021.


The Trust confirmed her appointment on Monday (17 March) following a competitive recruitment process and approval by the Council of Governors.

She will succeed Professor Ian Abbs, who announced in January that he will stand down in 2025.

Returning to an expanded organisation following its merger with Royal Brompton and Harefield Hospitals in 2021, Pritchard will lead one of the largest NHS Trusts in the country.

Charles Alexander, chairman of Guy’s and St Thomas’, praised Pritchard’s outstanding vision for the Trust.

He said: "We were extremely impressed by Amanda’s enthusiasm, energy and commitment to the future success of Guy’s and St Thomas’.

“She will return to a very different organisation from the one that she left 6 years ago and clearly demonstrated her vision and support for our ambitious plans, combined with the need to lead transformational change at pace.”

“We and our local healthcare and academic partners are fortunate that we will be able to benefit from the significant experience that Amanda has acquired during her time at NHS England as she returns to a role in frontline healthcare delivery.”

Expressing her pride in rejoining the Trust, Pritchard acknowledged the changes since her departure in 2019.

“It is an honour to be appointed to the role of Chief Executive at Guy’s and St Thomas’ – the organisation is now very different to the one I left in 2019 and I am delighted and proud to return to lead it,” she said.

“Guy’s and St Thomas’ is one of the country’s leading providers and I am very much looking forward to connecting with colleagues old and new as, together, we work to improve and transform the experiences of our staff and patients,” she added.

Pritchard first joined Guy’s and St Thomas’ as chief operating officer in 2012. Before that, she held several senior positions at Chelsea and Westminster NHS Foundation Trust and worked in the Prime Minister’s Delivery Unit.


More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less